Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07430852

Inherited and Environmental Risks Acting on Body Weight

The goal of this research is to investigate genetic and environmental factors that contribute to obesity through brain inflammation. The main questions are 1) if identical twins, who differ in food consumption habits, have differences in adiposity markers and brain inflammation and 2) if signs of brain inflammation in response to a specific diet is modified by genetics.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

In study 1, participant twin pairs that differ in habitual diet intake, will complete an in-person study visit that includes an MRI of the brain and abdomen, body composition measurement, a blood draw and questionnaires. In study 2, a different set of participant twin pairs will complete 3 in-person study visits over 2 weeks, during which all meals will be provided by the study. Visits will include brain MRI, body composition measurements, blood draws and questionnaires.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 20-45 years
  • Differs in habitual diet from co-twin (study 1).
  • Willing to undergo 7-day overfeeding and hypocaloric feeding periods (study 2)
  • Member of the Washington State Twin Registry

Exclusion criteria

  • History of bariatric surgery or active participation in weight-loss program
  • Major medical or neurological disorder (e.g., diabetes, multiple sclerosis)
  • Known gallbladder disease, anemia, impaired thyroid, kidney or liver function or hypertriglyceridemia (>350 mg/dl) (study 2)
  • Current use of weight-loss medications or other medications known to alter appetite (e.g., atypical anti-psychotics)
  • High levels of vigorous physical activity (>300 min./week)
  • Pregnancy, menopause, or breastfeeding
  • Individuals with severe food allergies and dietary restrictions (e.g., vegan/vegetarian, gluten-free, others) (study 2)
  • Co-twin unwilling or unable to participate
  • MRI contraindication (e.g., implanted metal, claustrophobia)
  • Lifetime eating disorder
  • Current smoking or heavy alcohol use (≥ 2 drinks per day for females and ≥ 3 drinks per day for males)
  • BMI > 45 kg/m2 (study 1)
  • BMI > 35 kg/m2 (study 2)
  • Weight > 350 pounds or determined to be safe by MRI tech (MRI limit)
  • Inability to participate in a controlled diet program (study 2) or undergo other study procedures
  • Non-English speaking-or-reading individuals

Treatment and study plan

Diet modification

Behavioral

Participants will be provided all meals for a 14-day period. For 7 of the days, meals will be 150% of estimated daily caloric needs and for the other 7 days, meals will be low in calories, consistent with recommendations for weight loss.

Primary outcomes

  1. Study 1: Hypothalamic Gliosis

    Time frame: at enrollment

    T2 relaxation time as measured by brain MRI

  2. Study 2: Hypothalamic Gliosis

    Time frame: 7 days of diet intervention

    T2 relaxation time as measured by brain MRI

Study contacts

Contact information is provided by the study sponsor or research team.

INTERACT Study

CONTACT

[email protected]

206-616-6360

Sponsors and collaborators

Lead sponsor

University of Washington

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Official study title

Genetic and Environmental Contributions to Obesity Pathogenesis

Acronym: INTERACT

Important dates

Study start
2026
Primary completion
2029
Study completion
2030
First posted
Feb 24, 2026
Registry last updated
Feb 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.